The invention relates to pyrrolidine derivatives of formula
wherein
R
1
,
R
2
,
R
3
,
n, and o are defined in the specification and to pharmaceutically active acid-addition salts thereof. Compounds of formula I have a high affinity simultaneously to both the NK1 and the NK3 receptors (dual NK1/NK3 receptor antagonists), useful in the treatment of schizophrenia.
该发明涉及式中的
吡咯烷衍
生物,其中R1、R2、R3、n和o在规范中定义,并且其药用活性酸盐。式I的化合物同时具有高亲和力,既对NK1受体又对NK3受体(双重NK1/NK3受体拮抗剂),可用于治疗精神分裂症。